Difference between revisions of "WSI22-117-Case-7"

From MGH Learn Pathology
Line 14: Line 14:
 
|performer=BQ01
 
|performer=BQ01
 
|bodySite=ENDOMETRIUM; CURETTAGE
 
|bodySite=ENDOMETRIUM; CURETTAGE
|reasonCode=Same patient as Case 6, but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
+
|reasonCode=Same patient as previous case (Case 6), but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
 
|supportingInfo=Retained Partial Hydatidiform Mole
 
|supportingInfo=Retained Partial Hydatidiform Mole
 
}}
 
}}

Revision as of 14:25, August 24, 2022

WSI22-117-Case-7
Same patient as previous case (Case 6), but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
Retained Partial Hydatidiform Mole
August 20, 2024 12:00:00 PM